Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Low Dose

View:

Post by TheMadMonk on Sep 05, 2021 12:46pm

Low Dose

Do we have an estimated time frame for when we can expect the company to have a lowest effective dose for OTENA?

156

Comment

Comment by MrMugsy on Sep 05, 2021 1:41pm

Hey MadMonk ... we are waiting to see if we can go lower than 100 mg ... that's what we need first. Management said we'd know in October. I sure hope they can better that. 1. If we can't go lower then we should have a pretty good idea where the lowest is ... 100, 150 or 200 mg. Make go-forward plans from there. 2. If we can go lower, I would assume a ...more

139

Comment